Role of the molybdoflavoenzyme aldehyde oxidase homolog 2 in the biosynthesis of retinoic acid: Generation and characterization of a knockout mouse

Molecular and Cellular Biology

Volumn 29, Issue 2, 2009, Pages 357-377

  Terao, Mineko ^a   Kurosaki, Mami ^a   Barzago, Maria Monica ^a   Fratelli, Maddalena ^a   Bagnati, Renzo ^a   Bastone, Antonio ^a   Giudice, Chiara ^b   Scanziani, Eugenio ^b   Mancuso, Alessandra ^c,d   Tiveron, Cecilia ^c,e   Garattini, Enrico ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALDEHYDE OXIDASE; LIPID; MOLYBDOFLAVOENZYME ALDEHYDE OXIDASE HOMOLOG 2; RETINAL; RETINOIC ACID; RETINOID; TESTOSTERONE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL SECRETION; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; FEMALE; HARDER GLAND; HOMEOSTASIS; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LIGHT EXPOSURE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION; UNINDEXED SEQUENCE; UPREGULATION;

AGING; ALDEHYDE OXIDOREDUCTASES; ANIMALS; ENDOCYTOSIS; EPIDERMIS; EXOCYTOSIS; FEMALE; FLAVOPROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HARDERIAN GLAND; HYPERTROPHY; LIPIDS; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINALDEHYDE; SEBACEOUS GLANDS; SEX CHARACTERISTICS; TESTOSTERONE; TRETINOIN;

ANIMALIA; MUS;

EID: 58249104034     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01385-08     Document Type: Article

References (77)

1. Alique, M., F. J. Lucio-Cazana, V. Moreno, Q. Xu, T. Konta, K. Nakayama, A. Furusu, J. C. Sepulveda, and M. Kitamura. 2007. Upregulation of cy-clooxygenases by retinoic acid in rat mesangial cells. Pharmacology 79:57-64.
2. Al-Salmy, H. S. 2001. Individual variation in hepatic aldehyde oxidase activity. IUBMB Life 51:249-253.
3. Anzano, M. A., A. J. Lamb, and J. A. Olson. 1981. Impaired salivary gland secretory function following the induction of rapid, synchronous vitamin A deficiency in rats. J. Nutr. 111:496-504.
4. Attar, P. S., P. W. Wertz, M. McArthur, S. Imakado, J. R. Bickenbach, and D. R. Roop. 1997. Inhibition of retinoid signaling in transgenic mice alters lipid processing and disrupts epidermal barrier function. Mol. Endocrinol. 11:792-800.
5. Balmer, J. E., and R. Blomhoff. 2002. Gene expression regulation by retinoic acid. J. Lipid Res. 43:1773-1808.
6. Beedham, C. 1987. Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity. Prog. Med. Chem. 24:85-127.
7. Beedham, C. 1997. The role of non-P450 enzymes in drug oxidation. Pharm. World Sci. 19:255-263.
8. Beedham, C., Y. al-Tayib, and J. A. Smith. 1992. Role of guinea pig and rabbit hepatic aldehyde oxidase in oxidative in vitro metabolism of cinchona antimalarials. Drug Metab. Dispos. 20:889-895.
9. Beedham, C., S. E. Bruce, and D. J. Rance. 1987. Tissue distribution of the molybdenum hydroxylases, aldehyde oxidase and xanthine oxidase, in male and female guinea pigs. Eur. J. Drug Metab. Pharmacokinet. 12:303-306.
10. Beedham, C., J. J. Miceli, and R. S. Obach. 2003. Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J. Clin. Psychopharmacol. 23: 229-232.
11. Beedham, C., C. F. Peet, G. I. Panoutsopoulos, H. Carter, and J. A. Smith. 1995. Role of aldehyde oxidase in biogenic amine metabolism. Prog. Brain Res. 106:345-353.
12. Bendotti, C., E. Prosperini, M. Kurosaki, E. Garattini, and M. Terao. 1997. Selective localization of mouse aldehyde oxidase mRNA in the choroid plexus and motor neurons. Neuroreport 8:2343-2349.
13. Berger, R., E. Mezey, K. P. Clancy, G. Harta, R. M. Wright, J. E. Repine, R. H. Brown, M. Brownstein, and D. Patterson. 1995. Analysis of aldehyde oxidase and xanthine dehydrogenase/oxidase as possible candidate genes for autosomal recessive familial amyotrophic lateral sclerosis. Somat. Cell Mol. Genet. 21:121-131.
14. Buzzell, G. R. 1996. The Harderian gland: perspectives. Microsc. Res. Tech. 34:2-5.
15. Buzzell, G. R. 1996. Sexual dimorphism in the Harderian gland of the Syrian hamster is controlled and maintained by hormones, despite seasonal fluctuations in hormone levels: functional implications. Microsc. Res. Tech. 34: 133-138.
16. Buzzell, G. R., J. L. Blank, M. K. Vaugian, and R. J. Reiter. 1995. Control of secretory lipid droplets in the Harderian gland by testosterone and the photoperiod: comparison of two species of hamsters. Gen. Comp. Endocri-nol. 99:230-238.
17. Byrne, C., M. Tainsky, and E. Fucis. 1994. Programming gene expression in developing epidermis. Development 120:2369-2383.
18. Ciambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940-954.
19. Chang, L., J. Zhang, Y. H. Tseng, C. Q. Xie, J. Ilany, J. C. Bruning, Z. Sun, X. Zhu, T. Cui, K. A. Youker, Q. Yang, S. M. Day, C. R. Kahn, and Y. E. Chen. 2007. Rad GTPase deficiency leads to cardiac hypertrophy. Circulation 116:2976-2983.
20. Chou, C. F., C. L. Lai, Y. C. Chang, G. Duester, and S. J. Yin. 2002. Kinetic mechanism of human class IV alcohol dehydrogenase functioning as retinol dehydrogenase. J. Biol. Chem. 277:25209-25216.
21. Conchon, S., X. Cao, C. Barlowe, and H. R. Pelham. 1999. Got1p and Sft2p: membrane proteins involved in traffic to the Golgi complex. EMBO J. 18: 3934-3946.
22. Dupe, V., N. Matt, J. M. Garnier, P. Ciambon, M. Mark, and N. B. Giy-selinck. 2003. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. USA 100:14036-14041.
23. Fisier, G. J., and J. J. Vooriees. 1996. Molecular mechanisms of retinoid actions in skin. FASEB J. 10:1002-1013.
24. Gao, J., L. Estrada, S. Cio, R. E. Ellis, and J. L. Gorski. 2001. The Caeno-rhabditis elegans homolog of FGD1, the human Cdc42 GEF gene responsible for faciogenital dysplasia, is critical for excretory cell morphogenesis. Hum. Mol. Genet. 10:3049-3062.
25. Garattini, E., M. Fratelli, and M. Terao. 2008. Mammalian aldehyde oxi-dases: genetics, evolution and biochemistry. Cell. Mol. Life Sci. 65:1019-1048.
26. Garattini, E., M. Gianni, and M. Terao. 2007. Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents. Vitam. Horm. 75:301-354.
27. Garattini, E., M. Gianni, and M. Terao. 2007. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations. Curr. Pharm. Des. 13:1375-1400.
28. Garattini, E., R. Mendel, M. J. Romao, R. Wright, and M. Terao. 2003. Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochem. J. 372: 15-32.
29. Huber, W., A. von Heydebreck, H. Sultmann, A. Poustka, and M. Vingron. 2002. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl. 1):S96-S104.
30. Ito, K., T. Suzuki, T. Moriya, H. Utsunomiya, A. Sugawara, R. Konno, S. Sato, and H. Sasano. 2001. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydro-genase. J. Clin. Endocrinol. Metab. 86:2721-2727.
31. Jeyaraj, D. A., G. Grossman, and P. Petrusz. 2005. Altered bioavailability of testosterone in androgen-binding protein-transgenic mice. Steroids 70:704-714.
32. Joulia-Ekaza, D., and G. Cabello. 2007. The myostatin gene: physiology and pharmacological relevance. Curr. Opin. Pharmacol. 7:310-315.
33. Joyner, A. L. 2000. Gene targeting: a practical approach, 2nd ed. Oxford University Press, Oxford, United Kingdom.
34. Kilani, R. T., A. Medina, A. Aitken, R. B. Jalili, M. Carr, and A. Ghahary. 2008. Identification of different isoforms of 14-3-3 protein family in human dermal and epidermal layers. Mol. Cell. Biochem. 314:161-169.
35. Kundu, T. K., R. Hille, M. Velayutiam, and J. L. Zweier. 2007. Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues. Arch. Biochem. Biophys. 460:113-121.
36. Kurosaki, M., S. Demontis, M. M. Barzago, E. Garattini, and M. Terao. 1999. Molecular cloning of the cDNA coding for mouse aldehyde oxidase: tissue distribution and regulation in vivo by testosterone. Biochem. J. 341: 71-80.
37. Kurosaki, M., M. Terao, M. M. Barzago, A. Bastone, D. Bernardinello, M. Salmona, and E. Garattini. 2004. The aldehyde oxidase gene cluster in mice and rats. Aldehyde oxidase homologue 3, a novel member of the molybdo-flavoenzyme family with selective expression in the olfactory mucosa. J. Biol. Chem. 279:50482-50498.
38. Lee, H. K., W. Braynen, K. Kesiav, and P. Pavlidis. 2005. ErmineJ: tool for functional analysis of gene expression data sets. BMC Bioinformatics 6:269.
39. Madani, K. A., G. S. Bazzano, and A. C. Ciou. 1985. The in vitro metabolism of 13-cis-retinoic acid in a model sebaceous structure, the rat preputial gland. J. Investig. Dermatol. 85:465-469.
40. Madison, K. C. 2003. Barrier function of the skin: "la raison d'etre" of the epidermis. J. Investig. Dermatol. 121:231-241.
41. Majkic-Singi, N., B. Contei, M. Stojanov, and I. Berkes. 1983. Kinetic assay of aldehyde oxidase with 2,2′-azino-di-(3- ethylbenzthiazoline-6-sulfonate) as chromogen. Enzyme 29:120-125.
42. Mira, L., L. Maia, L. Barreira, and C. F. Manso. 1995. Evidence for free radical generation due to NADH oxidation by aldehyde oxidase during ethanol metabolism. Arch. Biochem. Biophys. 318:53-58.
43. Molotkov, A., and G. Duester. 2003. Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream ofalcohol dehydro-genase Adh1 in metabolism of retinol to retinoic acid. J. Biol. Chem. 278: 36085-36090.
44. Nagy, A., M. Gertsenstein, K. Vintersten, and R. Behringer. 2003. Manipulating the mouse embryo, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
45. Niederreither, K., and P. Dolle. 2008. Retinoic acid in development: towards an integrated view. Nat. Rev. Genet. 9:541-553.
46. Nishimura, M., and S. Naito. 2006. Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab. Pharmacokinet. 21:357-374.
47. Okada, K., H. R. Lijnen, M. Dewerchin, A. Belayew, O. Matsuo, D. Collen, and R. Bernaerts. 1997. Characterization and targeting of the murine alpha2-antiplasmin gene. Thromb. Haemost. 78:1104-1110.
48. Panoutsopoulos, G. I., and C. Beedham. 2004. Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes. Acta Biochim. Pol. 51:649-663.
49. Panoutsopoulos, G. I., D. Kouretas, and C. Beedham. 2004. Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes. Chem. Res. Toxicol. 17:1368-1376.
50. Panoutsopoulos, G. I., D. Kouretas, E. G. Gounaris, and C. Beedham. 2004. Metabolism of 2-phenylethylamine and phenylacetaldehyde by precision-cut guinea pig fresh liver slices. Eur. J. Drug Metab. Pharmacokinet. 29:111-118.
51. Penela, P., C. Ribas, I. Aymerich, N. Eijkelkamp, O. Barreiro, C. J. Heijnen, A. Kavelaars, F. Sanchez-Madrid, and F. Mayor, Jr. 2008. G protein-coupled receptor kinase 2 positively regulates epithelial cell migration. EMBO J. 27:1206-1218.
52. Pogach, M. S., Y. Cao, G. Millien, M. I. Ramirez, and M. C. Williams. 2007. Key developmental regulators change during hyperoxia-induced injury and recovery in adult mouse lung. J. Cell. Biochem. 100:1415- 1429.
53. Rashidi, M. R., C. Beedham, J. S. Smith, and S. Davaran. 2007. In vitro study of 6-mercaptopurine oxidation catalysed by aldehyde oxidase and xanthine oxidase. Drug Metab. Pharmacokinet. 22:299-306.
54. Rashidi, M. R., J. A. Smith, S. E. Clarke, and C. Beedham. 1997. In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. Drug Metab. Dispos. 25:805-813.
55. Rehorek, S. J., and T. D. Smith. 2006. The primate Harderian gland: does it really exist? Ann. Anat. 188:319-327.
56. Richardson, R. J., J. Dixon, S. Malhotra, M. J. Hardman, L. Knowles, R. P. Boot-Handford, P. Shore, A. Whitmarsh, and M. J. Dixon. 2006. Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat. Genet. 38:1329-1334.
57. Rittie, L., J. Varani, S. Kang, J. J. Vooriees, and G. J. Fisher. 2006. Reti-noid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J. Investig. Dermatol. 126:732-739.
58. Schirren, C. G., T. Jansen, A. Lindner, P. Kind, and G. Plewig. 1996. Diffuse sebaceous gland hyperplasia. A case report and an immunohistochemical study with cytokeratins. Am. J. Dermatopathol. 18:296-301.
59. Schug, T. T., D. C. Berry, N. S. Shaw, S. N. Travis, and N. Noy. 2007. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129:723-733.
60. Schug, T. T., D. C. Berry, I. A. Toshkov, L. Cheng, A. Y. Nikitin, and N. Noy. 2008. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc. Natl. Acad. Sci. USA 105:7546-7551.
61. Schwab, S. R., J. P. Pereira, M. Matloubian, Y. Xu, Y. Huang, and J. G. Cyster. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309:1735-1739.
62. Semple, R. K., V. K. Chatterjee, and S. O'Rahilly. 2006. PPAR gamma and human metabolic disease. J. Clin. Investig. 116:581-589.
63. Shaw, N., M. Elholm, and N. Noy. 2003. Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta. J. Biol. Chem. 278:41589-41592.
64. Sigruener, A., C. Buechler, E. Orso, A. Hartmann, P. J. Wild, L. Terracciano, M. Roncalli, S. R. Bornstein, and G. Schmitz. 2007. Human aldehyde oxi-dase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes. Horm. Metab. Res. 39:781-789.
65. Terao, M., M. Kurosaki, M. M. Barzago, E. Varasano, A. Boldetti, A. Bas-tone, M. Fratelli, and E. Garattini. 2006. Avian and canine aldehyde oxi-dases. Novel insights into the biology and evolution of molybdo-flavoen- zymes. J. Biol. Chem. 281:19748-19761.
66. Terao, M., M. Kurosaki, S. Demontis, S. Zanotta, and E. Garattini. 1998. Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin. Biochem. J. 332:383-393.
67. Terao, M., M. Kurosaki, M. Marini, M. A. Vanoni, G. Saltini, V. Bonetto, A. Bastone, C. Federico, S. Saccone, R. Fanelli, M. Salmona, and E. Garattini. 2001. Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes. Identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1. J. Biol. Chem. 276:46347-46363.
68. Terao, M., M. Kurosaki, G. Saltini, S. Demontis, M. Marini, M. Salmona, and E. Garattini. 2000. Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase. J. Biol. Chem. 275:30690-30700.
69. Vassar, R., and E. Fuchs. 1991. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev. 5:714-727.
70. Vila, R., M. Kurosaki, M. M. Barzago, M. Kolek, A. Bastone, L. Colombo, M. Salmona, M. Terao, and E. Garattini. 2004. Regulation and biochemistry of mouse molybdo-flavoenzymes. The DBA/2 mouse is selectively deficient in the expression of aldehyde oxidase homologues 1 and 2 and represents a unique source for the purification and characterization of aldehyde oxidase. J. Biol. Chem. 279:8668-8683.
71. Vorbach, C., A. Scriven, and M. R. Capecchi. 2002. The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland. Genes Dev. 16: 3223-3235.
72. Weigert, J., M. Neumeier, S. Bauer, W. Mages, A. A. Schnitzbauer, A. Obed, B. Groschl, A. Hartmann, A. Schaffler, C. Aslanidis, J. Scholmerich, and C. Buechler. 2008. Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release. FEBS Lett. 582:2965-2972.
73. Wrobel, A., H. Seltmann, S. Fimmel, K. Muller-Decker, M. Tsukada, B. Bogdanoff, N. Mandt, U. Blume-Peytavi, C. E. Orfanos, and C. C. Zouboulis. 2003. Differentiation and apoptosis in human immortalized sebocytes. J. In-vestig. Dermatol. 120:175-181.
74. Zhuang, Y. H., M. Blauer, M. Pelto-Huikko, H. Syvala, and P. Tuohimaa. 1996. Immunochemical and in situ hybridization analyses of retinoic acid receptor alpha, beta, and gamma in murine Harderian and submandibular glands. Histochem. Cell Biol. 106:311-318.
75. Zhuang, Y. H., E. L. Sainio, P. Sainio, W. V. Vedeckis, T. Ylikomi, and P. Tuohimaa. 1995. Distributionofall-trans-retinoicacid innormalandvitamin A deficient mice: correlation to retinoic acid receptors in different tissues of normal mice. Gen. Comp. Endocrinol. 100:170-178.
76. Ziouzenkova, O., G. Orasanu, M. Sharlach, T. E. Akiyama, J. P. Berger, J. Viereck, J. A. Hamilton, G. Tang, G. G. Dolnikowski, S. Vogel, G. Duester, and J. Plutzky. 2007. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat. Med. 13:695-702.
77. Ziouzenkova, O., and J. Plutzky. 2008. Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett. 582:32-38.